Maze Therapeutics, Inc. (MAZE)
46.90
-0.14
(-0.30%)
USD |
NASDAQ |
Feb 13, 15:41
Maze Therapeutics Cash from Investing (Quarterly) : -66.88M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CDT Equity, Inc. | -0.998M |
| LENZ Therapeutics, Inc. | -4.333M |
| Liminatus Pharma, Inc. | -0.0131M |
| Oruka Therapeutics, Inc. | -122.45M |
| MapLight Therapeutics, Inc. | -135.59M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -24.64M |
| Cash from Financing (Quarterly) | 143.76M |
| Free Cash Flow | -108.03M |
| Free Cash Flow Per Share (Quarterly) | -0.514 |
| Free Cash Flow to Equity (Quarterly) | -23.88M |
| Free Cash Flow to Firm (Quarterly) | -24.71M |
| Free Cash Flow Yield | -5.13% |